Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Anti-Neuroinflammatory Properties of N-3 Fatty Acids and Nanocurcumin on Migraine Patients From Cellular to Clinical Insight: A Randomized, Double-Blind and Placebo-Controlled Trial Publisher Pubmed



Honarvar NM1 ; Soveid N1 ; Abdolahi M1 ; Djalali M1 ; Hatami M1 ; Karzar NH2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Neuroendocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States

Source: Endocrine# Metabolic and Immune Disorders - Drug Targets Published:2021


Abstract

Background and Objectives: Migraine is an exhausting neuro-inflammatory disorder recognized as recurrent headache attacks. Evidence has shown that Interleukin (IL)-1β plays a substantial role in the neuro-immunity pathogenicity of migraine. n-3 fatty acids and curcumin revealed neuromodulatory and anti-inflammatory effects through several pathways, of which the suppression of IL-1β gene expression is an important inflammatory pathway. The aim of this study was the investigation of synergistic relation of n-3 fatty acids and nano-curcumin on IL-1β gene expression and serum levels in migraine patients. Methods: This study was performed as a randomized, double-blind, placebo-controlled trial in a period of two months. A total of 80 episodic migraines were assigned into 4 groups of 1) n-3 fatty acids and curcumin combination; 2) n-3 fatty acids; 3) nano-curcumin; and 4) n-3 fatty acids and curcumin placebo. The gene expression and serum level of IL-1β were measured by real-time PCR and ELISA methods respectively, at the beginning and the end of the interventions. Results: Results showed the n-3 fatty acids and nano-curcumin combination significantly reduced the attack frequency in a synergistic status (P < 0.001). A significantly greater reduction in the serum level of IL-1β was observed in the combination group, and the differences in the other groups were not statistically significant. The IL-1β gene expression in the combination group showed a significant reduction for other treatment groups (P < 0.05), but these significant differences were absent after multiple testing Bonferroni corrections. Conclusion: Present findings revealed that n-3 fatty acids and curcumin co-supplementation can be suggested as a promising new approach in migraine headache management, but further studies are needed to confirm these findings. © 2021 Bentham Science Publishers.
7. Dietary Supplementation in Migraine: A Focus on Omega-3 Fatty Acids, Treatments# Nutraceuticals# Supplements# and Herbal Medicine in Neurological Disorders (2023)
Experts (# of related papers)
Other Related Docs
10. Review on Headache Related to Dietary Supplements, Current Pain and Headache Reports (2022)
17. Evaluation of Inflammatory State in Migraineurs: A Case-Control Study, Iranian Journal of Allergy# Asthma and Immunology (2020)